Mediclinic International (Mediclinic International) Risk Assessment

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Mediclinic International is: No Data: Cannot be evaluated.

Competitive Comparison of Mediclinic International's Risk Assessment

For the Medical Care Facilities subindustry, Mediclinic International's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mediclinic International's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mediclinic International's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Mediclinic International's Risk Assessment falls into.

Mediclinic International (OTCPK:ANHGY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Mediclinic International Risk Assessment Related Terms

Thank you for viewing the detailed overview of Mediclinic International's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.